Last reviewed 2026-04-23 · How we verify

one dose test vaccine

This vaccine induces an immune response to prevent COVID-19 infection.

This vaccine induces an immune response to prevent COVID-19 infection. Used for Prevention of COVID-19 disease.

At a glance

Mechanism of action

The vaccine works by introducing a piece of genetic material from the SARS-CoV-2 virus to the body, which triggers an immune response and produces antibodies to fight the virus.

Approved indications

• Prevention of COVID-19 disease

Common side effects

• Pain, redness, or swelling at the injection site
• Fatigue
• Headache

Key clinical trials

• A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) (PHASE4)
• SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years (PHASE3)
• Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy (EARLY_PHASE1)
• Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women (PHASE3)
• Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study
• Safety and Immunogenicity of ID vs IM Rabies Vaccine (PHASE2, PHASE3)
• A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults (PHASE1, PHASE2)
• Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. (EARLY_PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.